LDRT
Clinical trials for LDRT explained in plain language.
Never miss a new study
Get alerted when new LDRT trials appear
Sign up with your email to follow new studies for LDRT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could low-dose radiation boost immunotherapy for liver-limited colorectal cancer?
Disease control Recruiting nowThis early-phase study is testing whether adding low-dose radiotherapy to standard immunochemotherapy is safe and feasible for people with colorectal cancer that has spread only to the liver. About 9 to 18 adults aged 18-75 who have not had prior treatment will receive the combin…
Matched conditions: LDRT
Phase: PHASE1 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
New combo therapy aims to boost immune attack on hard-to-treat pancreatic cancer
Disease control Recruiting nowThis study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help control advanced pancreatic cancer. About 10 adults who have not had prior immunotherapy will receive the combination. The goal is to see if the treatment shri…
Matched conditions: LDRT
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC